Xeris Biopharma Holdings Inc. (XERS) NASDAQ
$1.78 (0.02) (-1.11%)
Market Cap: $250.01M
As of 04/17/24 04:00 PM EDT. Market closed.
Xeris Biopharma Holdings Inc. (XERS)
NASDAQ
$1.78
(0.02) (-1.11%)
Market Cap: $250.01M
As of 04/17/24 04:00 PM EDT. Market closed.
Add to Portfolio
xeris aspires to break through this restraint by developing ultra-low volume, ready-to-use biotherapeutics delivered through patient-friendly injectable devices. products built on our xeriject technologies could potentially ease the pain of injections for hundreds of millions of ... read more
xeris aspires to break through this restraint by developing ultra-low volume, ready-to-use biotherapeutics delivered through patient-friendly injectable devices. products built on our xeriject technologies could potentially ease the pain of injections for hundreds of millions of patients. read less
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Full Time Employees
360
Address
.
PRICE CHART FOR XERIS BIOPHARMA HOLDINGS INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
$1.80
Days Range
$1.75 - $1.83
52 week range
$1.46 - $3.26
Volume
1,521,288
Avg. Volume (30 days)
1,471,232
Market Cap
$250.01M
Dividend Yield
-
P/E
(4.02)
Shares Outstanding
140,453,467
Open
-
Previous Close
$1.80
Days Range
$1.75 - $1.83
52 week range
$1.46 - $3.26
Volume
1,521,288
Avg. Volume (30 days)
1,471,232
Market Cap
$250.01M
Dividend Yield
-
P/E
(4.02)
Shares Outstanding
140,453,467
FINANCIAL STATEMENTS FOR XERIS BIOPHARMA HOLDINGS INC
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR XERIS BIOPHARMA HOLDINGS INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| JOHNSON JOHN | Director | Mar 18, 2024 | Option Exercise | $1.99 | 215,600 | 429,044 | 751,412 | Mar 18, 2024, 05:32 PM |
| Schmid John P. | Director | Mar 14, 2024 | Buy | $2.16 | 4,500 | 9,720 | 11,000 | Mar 14, 2024, 09:03 PM |
| SHERMAN JEFFREY W | Director | Nov 27, 2023 | Buy | $1.87 | 5,400 | 10,098 | 5,400 | Nov 29, 2023, 04:09 PM |
| HALKUFF DAWN | Director | Nov 20, 2023 | Buy | $1.84 | 5,410 | 9,954 | 5,410 | Nov 21, 2023, 04:20 PM |
| Pieper Steven | See Remarks | Nov 20, 2023 | Buy | $1.95 | 28,000 | 54,600 | 1,176,912 | Nov 21, 2023, 04:16 PM |
| Schmid John P. | Director | Nov 16, 2023 | Buy | $1.51 | 6,500 | 9,815 | 6,500 | Nov 17, 2023, 06:35 PM |
| Shannon John Patrick Jr | See Remarks | Nov 17, 2023 | Buy | $1.64 | 30,769 | 50,400 | 1,408,575 | Nov 17, 2023, 05:58 PM |
| PERSKY MARLA | Director | Nov 14, 2023 | Buy | $1.58 | 6,370 | 10,058 | 6,370 | Nov 15, 2023, 04:13 PM |
| Edick Paul R | See Remarks | Aug 09, 2023 | Buy | $2.38 | 10,000 | 23,794 | 2,288,064 | Aug 09, 2023, 06:57 PM |
| Edick Paul R | See Remarks | Dec 13, 2022 | Buy | $1.45 | 20,000 | 29,000 | 1,528,064 | Dec 14, 2022, 04:11 PM |
| BORMANN-KENNEDY BARBARA-JEAN ANNE | Director | Jun 08, 2022 | Option Exercise | $2.10 | 15,000 | 31,500 | 15,000 | Jun 09, 2022, 05:15 PM |
| Edick Paul R | See Remarks | May 12, 2022 | Buy | $1.40 | 100,000 | 140,380 | 1,508,064 | May 13, 2022, 04:19 PM |
| PRESTRELSKI STEVEN | Chief Scientific Officer | Feb 22, 2022 | Option Exercise | $0.69 | 11,228 | 7,747 | 581,008 | Feb 24, 2022, 04:28 PM |
| PRESTRELSKI STEVEN | Chief Scientific Officer | Feb 22, 2022 | Sale | $2.42 | 11,228 | 27,158 | 569,780 | Feb 24, 2022, 04:28 PM |
| Edick Paul R | See Remarks | Nov 15, 2021 | Buy | $2.28 | 20,000 | 45,664 | 33,430 | Nov 16, 2021, 04:25 PM |
| Shannon John Patrick Jr | See Remarks | Nov 12, 2021 | Buy | $2.10 | 60,000 | 126,000 | 363,829 | Nov 12, 2021, 05:12 PM |
| Shannon John Patrick Jr | See Remarks | Nov 11, 2021 | Buy | $2.09 | 40,000 | 83,500 | 303,829 | Nov 12, 2021, 05:12 PM |
| Edick Paul R | See Remarks | Nov 11, 2021 | Buy | $2.08 | 200,000 | 415,760 | 808,064 | Nov 12, 2021, 05:09 PM |
| Pieper Steven | See Remarks | Nov 10, 2021 | Buy | $2.00 | 25,000 | 49,918 | 183,108 | Nov 12, 2021, 05:06 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| JOHNSON JOHN | Director | 03/18/2024 | 429,044 |
| Schmid John P. | Director | 03/14/2024 | 9,720 |
| SHERMAN JEFFREY W | Director | 11/27/2023 | 10,098 |
| HALKUFF DAWN | Director | 11/20/2023 | 9,954 |
| Pieper Steven | See Remarks | 11/20/2023 | 54,600 |
| Schmid John P. | Director | 11/16/2023 | 9,815 |
| Shannon John Patrick Jr | See Remarks | 11/17/2023 | 50,400 |
| PERSKY MARLA | Director | 11/14/2023 | 10,058 |
| Edick Paul R | See Remarks | 08/09/2023 | 23,794 |
| Edick Paul R | See Remarks | 12/13/2022 | 29,000 |
| BORMANN-KENNEDY BARBARA-JEAN ANNE | Director | 06/08/2022 | 31,500 |
| Edick Paul R | See Remarks | 05/12/2022 | 140,380 |
| PRESTRELSKI STEVEN | Chief Scientific Officer | 02/22/2022 | 7,747 |
| PRESTRELSKI STEVEN | Chief Scientific Officer | 02/22/2022 | 27,158 |
| Edick Paul R | See Remarks | 11/15/2021 | 45,664 |
| Shannon John Patrick Jr | See Remarks | 11/12/2021 | 126,000 |
| Shannon John Patrick Jr | See Remarks | 11/11/2021 | 83,500 |
| Edick Paul R | See Remarks | 11/11/2021 | 415,760 |
| Pieper Steven | See Remarks | 11/10/2021 | 49,918 |
Load More Insider Transactions
FUNDS WITH A POSITION IN XERIS BIOPHARMA HOLDINGS INC
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| BLACKROCK INC. | 10,011,391 | 0.0006% | 6.8% | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 2,892,077 | 0.00071% | 4.28% | Other |
| RENAISSANCE TECHNOLOGIES LLC | 1,381,640 | 0.00503% | 35.18% | Other |
| D. E. SHAW & CO., INC. | 1,054,610 | 0.00217% | 20.47% | Other |
| TUDOR INVESTMENT CORP ET AL | 553,411 | 0.01% | -13.73% | Event Driven, Other |
| AQR CAPITAL MANAGEMENT LLC | 273,222 | 0.00121% | 546.22% | Other |
| ALPINE GLOBAL MANAGEMENT, LLC | 270,000 | 0.2% | -10% | Event Driven |
| FAIRFAX FINANCIAL HOLDINGS LTD/ CAN | 151,395 | 0.02% | No change | Value |
CHANGE IN SHARES OUTSTANDING FOR XERIS BIOPHARMA HOLDINGS INC
STOCK BUYBACKS FOR XERIS BIOPHARMA HOLDINGS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2023
0.05%
1Q
06/30/2023
0.58%
2Q
03/31/2023
0.72%
3Q
12/31/2022
1.57%
4Q
09/30/2022
1.60%
5Q
06/30/2022
1.92%
6Q
03/31/2022
2.29%
7Q
12/31/2021
74.79%
8Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR XERIS BIOPHARMA HOLDINGS INC
LOADING...